Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Licenses Parts of GeneExpress to Morphochem

NEW YORK, Feb. 19 - Gene Logic on Tuesday said that Morphochem has subscribed to parts of its GeneExpress technology.

Morphochem researchers will use the GeneExpress oncology DataSuite and the  Reports tool, which was designed to offer a body-wide assessment of targeted genes. 

Terms of the non-exclusive, multiyear agreement also call for Gene Logic to generate data from samples provided by Morphochem and then provide these additional data to Morphochem.

Financial details of deal were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.